drugset / Trial / NCT02725177
Ocular Sarcoidosis Open Label Trial of ACTHAR Gel
NaSingle-groupOpen-labelTreatment
Summary
Treatment with ACTHAR Gel will result in a reduction of ocular inflammation in patients with active ocular sarcoidosis that requires systemic immunosuppressant therapy (hypothesis)
Timeline
- Start
- 2016-07
- Primary completion
- 2021-12
- Completion
- 2022-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acthar | Peptide | 80 iu | — |